SALTIRE–RAAVE: targeting calcific aortic valve disease LDL-density-radius theory

References

• Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 2011;124:1783-91
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11
   PubMed Web of Science ®Google Scholar
• Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984;37:407-15
   PubMedGoogle Scholar
• Hoagland PM, Cook EF, Flatley M, et al. Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older). Am J Cardiol 1985;55:744-7
   PubMed Web of Science ®Google Scholar
• Aronow WS, Ahn C, Kronzon I, et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-5
   PubMed Web of Science ®Google Scholar
• Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987;59:998-9
   PubMed Web of Science ®Google Scholar
• Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors–a causal relationship? A clinical morphologic study. Clin Cardiol 1991;14:995-9
   PubMed Web of Science ®Google Scholar
• Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-70
   PubMed Web of Science ®Google Scholar
• Boon A, Cheriex E, Lodder J, et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-4
   PubMed Web of Science ®Google Scholar
• Chui MC, Newby DE, Panarelli M, et al. Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol 2001;24:52-5
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Stevenson RN, Griffiths H, et al. A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. Heart 1997;78:475-9
   PubMed Web of Science ®Google Scholar
• Chan KL, Ghani M, Woodend K, et al. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol 2001;88:690-3
   PubMed Web of Science ®Google Scholar
• Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006;47:2229-36
   PubMed Web of Science ®Google Scholar
• Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000;101:2497-502
   PubMed Web of Science ®Google Scholar
• Peltier M, Trojette F, Sarano ME, et al. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol 2003;91:97-9
   PubMed Web of Science ®Google Scholar
• Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4
   PubMed Web of Science ®Google Scholar
• Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly [comment]. N Engl J Med 1999;341:142-7
   PubMed Web of Science ®Google Scholar
• Faggiano P, Antonini-Canterin F, Baldessin F, et al. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound 2006;4:27
   PubMedGoogle Scholar
• Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104:1927-32
   PubMed Web of Science ®Google Scholar
• Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol 2014;63:2852-61
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Hirsu M, Popescu BA, et al. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol 2008;102:738-42
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Corrado G, Faggiano P, et al. A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography. J Cardiovasc Med (Hagerstown) 2006;7:464-9
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Popescu BA, Huang G, et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? Ital Heart J 2005;6:119-24
   PubMedGoogle Scholar
• Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;38:827-34
   PubMed Web of Science ®Google Scholar
• Dimitrow PP, Jawien M, Gackowski A. The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. J Heart Valve Dis 2011;20:18-22
   PubMed Web of Science ®Google Scholar
• Smith JG, Luk K, Schulz CA, et al. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA 2014;312:1764-71
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-17
   PubMed Web of Science ®Google Scholar
• Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61
   PubMed Web of Science ®Google Scholar
• Rossebo AB, Pedersen TR, Boman K, et al. Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis. N Engl J Med 2008;359(13):1343-56
   PubMed Web of Science ®Google Scholar
• Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14
   PubMed Web of Science ®Google Scholar
• Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2260-5
   Web of Science ®Google Scholar
• Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001;10:371-4
   PubMed Web of Science ®Google Scholar
• Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003;41:1211-17
   PubMed Web of Science ®Google Scholar
• Weiss RM, Ohashi M, Miller JD, et al. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006;114:2065-9
   PubMed Web of Science ®Google Scholar
• Aikawa E, Nahrendorf M, Sosnovik D, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007;115:377-86
   PubMed Web of Science ®Google Scholar
• Drolet MC, Roussel E, Deshaies Y, et al. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol 2006;47:850-5
   PubMed Web of Science ®Google Scholar
• Shao JS, Cheng SL, Pingsterhaus JM, et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20
   PubMed Web of Science ®Google Scholar
• Linefsky JP, O’Brien KD, Katz R, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: The cardiovascular health study. J Am Coll Cardiol 2011;58:291-7
   PubMed Web of Science ®Google Scholar
• Blevins TL, Peterson SB, Lee EL, et al. Mitral valvular interstitial cells demonstrate regional, adhesional, and synthetic heterogeneity. Cells Tissues Organs 2008;187:113-22
   PubMed Web of Science ®Google Scholar
• Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171:1407-18
   PubMed Web of Science ®Google Scholar
• Yip CY, Chen JH, Zhao R, et al. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009;29:936-42
   PubMed Web of Science ®Google Scholar
• Rajamannan NM. The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/-/Lrp5-/- mice. J Cell Biochem 2011;112:2987-91
   PubMed Web of Science ®Google Scholar
• Rajamannan NM. Calcific aortic valve disease: cellular origins of valve calcification. Arterioscler Thromb Vasc Biol 2011;31:2777-8
   PubMed Web of Science ®Google Scholar
• Rajamannan NM. Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice. J Cell Biochem 2012;113:1623-34
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Caira F, et al. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005;112:I229-34
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Stock SR, et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005;91:806-10
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Popescu BA, Huang G, et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? Ital Heart J 2005;6:119-24
   PubMedGoogle Scholar
• Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [comment]. J Am Coll Cardiol 2002;40:1723-30
   PubMed Web of Science ®Google Scholar
• Shavelle DM, Takasu J, Budoff MJ, et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium [comment]. Lancet 2002;359:1125-6
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5
   PubMed Web of Science ®Google Scholar
• Makkena B, Salti H, Subramaniam M, et al. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. J Am Coll Cardiol 2005;45:631-3
   PubMed Web of Science ®Google Scholar
• Rajamannan N, Best P, Antonini-Cantorin F, et al. SALTIRE-RAAVE Subanalysis: a Role for Statins in Aortic Valve Disease. J Am College Cardiol 2011;57:E1317
   Web of Science ®Google Scholar
• Rosuvastatin Affecting Aortic Valve Endothelium. Available from: https://clinicaltrials.gov/ct2/show/NCT00114491
   Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 63:2889-934
   Google Scholar
• Rajamannan NM. Mechanisms of aortic valve calcification: the LDL-density-radius theory a translation from cell signaling to physiology. Am J Physiol Heart Circ Physiol 2009; in press
   Web of Science ®Google Scholar
• Rajamannan NM. Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology. Am J Physiol Heart Circ Physiol 2010;298:H5-15
   Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S1-45
   PubMed Web of Science ®Google Scholar
• Dodge JTJr, Brown BG, Bolson EL, et al. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 1992;86:232-46
   PubMed Web of Science ®Google Scholar
• Oh J, Seward J, Tajik A. The Echo Manual. 2007;59-70:189-201
   Google Scholar
• Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80
   PubMed Web of Science ®Google Scholar
• Salminen A, Pussinen PJ, Payne JB, et al. Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages. Inflamm Res 2013;62:711-20
   PubMed Web of Science ®Google Scholar
• Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34:3035-87
   PubMed Web of Science ®Google Scholar
• Bruckert E. Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement. Atheroscler Suppl 2014;15:26-32
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Edwards WD, Spelsberg TC. Hypercholesterolemic aortic-valve disease. N Engl J Med 2003;349:717-18
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Spelsberg TC, Moura LM. Mitral valve disease in a patient with familial hypercholesterolemia. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia. Portuguese J Cardiol 2010;29:841-2
   Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 63:2438-88
   Google Scholar
• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012;42:S1-44
   PubMed Web of Science ®Google Scholar
• Goff DCJr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation 2014;129:S49-73
   PubMed Web of Science ®Google Scholar
• Pyorala K, Wood D. Prevention of coronary heart disease in clinical practice. European recommendations revised and reinforced. Eur Heart J 1998;19:1413-15
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-17
   PubMed Web of Science ®Google Scholar
• Goff DCJr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2935-59
   PubMed Web of Science ®Google Scholar
• Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013;368:503-12
   PubMed Web of Science ®Google Scholar
• Rajamannan NM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 2009;29:162-8
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Karsera D, Tumminello G, et al. Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur J Echocardiogr 2008;9:338-43
   PubMed Web of Science ®Google Scholar
• Lazaros G, Toutouzas K, Drakopoulou M, et al. Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis? Expert Rev Cardiovasc Ther 2013;11:863-77
   PubMedGoogle Scholar